To investigate the effects of ASNS deletion in tumor progression, we used a cell-line derived cancer xenograft Rag2/IL2RG (R2G2) mouse model and performed a tumorigenicity study to examine tumor growth in vivo. This evidence concerns the gene IL2RG and neoplasm.